Request Sample

Global Hospital-acquired Disease Testing Market

May 23, 2019

Global Hospital-acquired Disease Testing Market, By Test Type (Surgical Site Infection, Blood Stream Infection, Urinary Tract Infection, Pneumonia, Methicillin-resistant Staphylococcus Aureus), By End User (Nursing Homes & Maternity Centers, Hospitals & Intensive Care Units (ICUS), and Ambulatory Surgical & Diagnostic Centers), By Region (North America, Latin America, Europe, Asia-Pacific, Middle East and Africa) - Global Forecast, 2020-2025.

Report Code :FMR522      
Pages :200 Pages
Format :   PPT Format   PDF Format

The global hospital-acquired disease testing market was valued at US$ xx million in the year 2019. This market is estimated to be valued at US$ xx million in the year 2020 and is expected to reach US$ xx million by the year 2025, with an estimated CAGR of xx% during the forecast period (2020-2025). Hospital-acquired disease or nosocomial infection is a systemic or localized situation in patients which arises owing to the unfavorable reaction produced by contagious toxin substances and agents during medical care. Hospital-acquired diseases include surgical site infections, catheter-related blood stream infections, catheter-associated urinary tract infection, and ventilator-associated pneumonia.

Table 1. Global Hospital-acquired Disease Testing Market Synopsis

Parameters

Description

Market Value (US$ Mn) for the Period

2018-2025

Base Year

2019

Forecast Period

2020-2025

Market Segmentation (By Test Type)

Surgical Site Infection, Blood Stream Infection, Urinary Tract Infection, Pneumonia, Methicillin-resistant Staphylococcus Aureus 

Market Segmentation (By End User)

Nursing Homes & Maternity Centers, Hospitals & Intensive Care Units (ICUS), and Ambulatory Surgical & Diagnostic Centers

Regions Covered

North America, Latin America, Europe, Asia-Pacific, Middle East and Africa

Key Players Coverage

Thermo Fisher Scientific, Abbott Laboratories, Inc., Meridian Bioscience, Alere, Diatherix Laboratories, Becton, Siemens Healthcare, Dickinson and Company, Hologic, BioMerieux SA, Cepheid, Luminex Corporation, F. Hoffmann-La Roche Ltd., Life Technologies, Nordion Inc., Cantel Medical Corporation, and Qiagen GmbH, among others

Key Insights

  • Latest Updates
  • Analyst Views
  • Future Outlook of the Market

Market Dynamics

The rising initiative of the companies and government to provide the better healthcare services to the patients by organizing the best possible facilities and innovations in terms of hospital-acquired disease. The rise in the health awareness among the patients, healthcare providers, and others leads to foster the demand for hospital-acquired disease testing market. Various medical device manufacturers are emphasizing on introducing the deep UV light emitting diodes that are smaller and portable disinfection devices to prevent the patients and individuals to get infected by the hospital-acquired disease. Therefore, this led to increase the demand for hospital-acquired disease testing market growth.

The increase in the launches of efficient and advanced testing kits and tools to provide the better healthcare to the patients and preventing them to get affected from the hospital-acquired infections is anticipated to thrive the demand for the hospital-acquired disease testing market. For instance, in December 2019, the company F. Hoffmann La Roche Ltd. received the approval from the FDA (Food and Drug Administration) for cobas vivoDx MRSA, an authorized test implemented to diagnose and detect the Methicillin-resistant Staphylococcus Aureus (MRSA) bacteria or infection.

However, the high cost of testing services and lack of awareness about the hospital-acquired infections are expected to hinder the hospital-acquired disease testing market over the forecast period.

Figure 1. PORTER’S Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

North America is anticipated to acquire the significant market share in the hospital-acquired disease testing market. The factors like geriatric population, rising incidence of hospital-acquired diseases, and the demand for development of health infrastructure are expected to pave the lucrative opportunity in the forecast period. For instance, in October 2016, according to the Centers for Disease Control and Prevention, in the U.S., one in every 25 hospital patients and visitors was affected by the hospital-acquired infection while the visit or being getting treated in the hospital.

Moreover, the era of COVID-19 has emerged the need for the developments and improvements in the healthcare industry to prevent the hospital-acquired infections and viruses, like corona in the patients and healthcare providers of the Asia-Pacific region. For instance, in March 2020, IIT (Indian Institute of Technology) Delhi, made anti-infection fabric to be used at hospitals to curb the hospital-acquired infections in the patients and the individuals of hospitals.

Figure 2. Regional Analysis

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

Competitive Landscape

Key players in the global hospital-acquired disease testing market include Thermo Fisher Scientific, Abbott Laboratories, Inc., Meridian Bioscience, Alere, Diatherix Laboratories, Becton, Siemens Healthcare, Dickinson and Company, Hologic, BioMerieux SA, Cepheid, Luminex Corporation, F. Hoffmann-La Roche Ltd., Life Technologies, Nordion Inc., Cantel Medical Corporation, and Qiagen GmbH, among others

The hospital-acquired disease testing market players are focusing on acquiring other companies to expand their product portfolio and enhance the efficiency of hospital-acquired disease testing. For instance, in April 2019, the company Meridian Bioscience, a provider of diagnostic testing solutions announced an agreement to acquire the business of GenePOC to develop the healthcare and provide the flexible multiplexing capability.

Furthermore, in March 2020, the company Thermo Fisher Scientific has acquired Qiagen N.V. to expand the specialty diagnostics portfolio with effective infectious disease testing and molecular diagnostics capabilities.

Figure 3. Market Share of Key Players, 2019

 

Note: The above figure is shown for illustrative purposes only, the actual data may vary and will be incorporated in the report.

By Test Type

  • Surgical Site Infection
  • Blood Stream Infection
  • Urinary Tract Infection
  • Pneumonia
  • Methicillin-resistant Staphylococcus Aureus

By End User

  • Nursing Homes & Maternity Centers
  • Hospitals & Intensive Care Units (ICUS)
  • Ambulatory Surgical & Diagnostic Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
rm
Kindly fill the below form and we will contact you within 24 hours
I have read and accept Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Note: This report provides in-depth analysis of the global hospital-acquired disease testing market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2025), considering 2019, as the base year.

  • What are the trends adopted by key players in the global hospital-acquired disease testing market?
  • What key factors are expected to increase the demand for hospital-acquired disease testing market during the forecast period 2020-2025?
  • What are the major challenges inhibiting the growth of the global hospital-acquired disease testing market?
  • What is the total market value (US$ Mn) generated in global hospital-acquired disease testing market by test type in 2019 and what are the forecasts by 2025?
  • Which end user contributes highest CAGR (%) in the hospital-acquired disease testing bank market?
  • What was the total revenue generated by the global hospital-acquired disease testing market across different regions (North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa) in 2019, along with CAGR (%) for the period (2020-2025)?
  • Who are the key players contributing to the growth of the global hospital-acquired disease testing market, and what are the new strategies adopted by them to retain a market share in the industry?
  • What is the competitive strength of the key players in the hospital-acquired disease testing market?
  • What are the major outcomes derived from the Porter’s five forces?
  • What new products are going to be approved or launched in the coming years which may have huge impact on the market?
  • What insights are derived through the analysis of key players on following parameters: company overview, financial performance, product portfolio, geographical presence, key highlights, and strategies?

Latest Reports

Global Sleep Testing Services Market

Global Sleep Testing Services Market, By Test Type (Home Sleep Testing and In-lab Sleep Testing (Electroencephalogram, Full Polysomnography, CPAP/BiPAP …

Read More

Global Sarcoma Biopsy Market

Global Sarcoma Biopsy Market, By Product Type (Reusable Device, Disposable Devices), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic …

Read More

Global Rheumatoid Arthritis Diagnostic Tests Market

Global Rheumatoid Arthritis Diagnostic Tests Market, By Test Type (serology tests (erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic …

Read More

Global PARP Inhibitor Biomarkers Market

Global PARP Inhibitor Biomarkers Market, By Product and Service Type (Product Type, (Kits, Assays), Service Type, (BRCA 1 & …

Read More

North America Outbound Medical Tourism Services Market

North America Outbound Medical Tourism Services Market, By Treatment Type (Cardiovascular Treatment, Cosmetic Surgery Treatment, Dental Treatment, Weight Loss …

Read More

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market

Global Methicillin Resistant Staphylococcus Aureus (MRSA) Testing Systems Market, By Product Type (Instruments and Reagents and Kits ), By …

Read More

Global Bilirubin Blood Test Market

Global Bilirubin Blood Test Market, By Test Type (Direct/Conjugated Bilirubin Test, Indirect/Unconjugated Bilirubin Test, Total Serum Bilirubin (TSB), By …

Read More

Global In Vitro Toxicity Testing Market

Global In Vitro Toxicity Testing Market, By Product & Service (Consumables, Assays (Bacterial Toxicity Assays, Enzyme Toxicity Assays, Cell-based …

Read More
Validation error occured. Please enter the fields and submit it again.